The impact of early SGLT2i inclusion in quadruple therapy for de novo patients: enhancing medication management and clinical outcomes

30 August 2025 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Novel insight into heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by